Israel
Medical device market intelligence for Israel. Regulatory changes, competitor moves, and procurement trends.
Last 7 days
RenalSense secured $14 million for Clarity RMS expansion in critical care monitoring across global markets.
PatenSee has begun a first-in-human trial for its contactless imaging system for haemodialysis patients' fistula stenosis.
PatenSee's contactless imaging device shows promise for timely monitoring of vascular access stenosis in dialysis patients.
The REDUCED-1 study for the TIVUS renal denervation system has completed patient enrollment for hypertension treatment.